Rhythm Control for Atrial Fibrillation May Dramatically Reduce Severity of Secondary Tricuspid Regurgitation
For patients with moderate-to-severe secondary tricuspid regurgitation (STR) and atrial fibrillation (AF), a new study offers compelling evidence that aggressive rhythm control strategies could significantly improve outcomes. Published in The Journal of the American College of Cardiology, the research demonstrates that successful maintenance of sinus rhythm—without recurrence of AF—is strongly associated with reduced severity of STR across diverse patient subgroups.
This breakthrough challenges conventional approaches that often prioritize rate control over rhythm control in AF patients. The findings suggest that early, aggressive attempts to restore normal heart rhythm may decrease the risk of STR progression and improve long-term prognosis.
Study Highlights: Rhythm Control and STR Improvement
Primary Finding
Patients who maintained sinus rhythm without AF recurrence were 3.65 times more likely (95% CI: 2.24–5.95) to experience a reduction in STR severity to mild or less, compared to those who did not achieve rhythm control. This association held true across all analyzed subgroups, including variations in AF type, left ventricular function and pulmonary hypertension status.
Patient Demographics and Study Design
- Total participants: 1,896 patients with moderate-to-severe STR and AF (median age 79; 60% women).
- Rhythm control attempts: 367 patients (19%) underwent rhythm control interventions within a median of 21 days.
- AF recurrence rate: 57% of those attempting rhythm control experienced AF recurrence, linked to older age, chronic/persistent AF, and lack of antiarrhythmic medication.
- Follow-up duration: Median of 1.7 years, with outcomes assessed via follow-up echocardiograms.
Subgroup Analysis: Who Benefits Most?
The study’s robustness lies in its subgroup analysis, which confirmed the benefits of rhythm control regardless of:
- STR etiology (left-sided valve disease, reduced LVEF, pulmonary hypertension, or isolated STR).
- Patient age, sex, or obesity status.
- AF burden, chronicity, or coexistent mitral regurgitation.
- Presence of right ventricular remodeling or pulmonary hypertension.
Key takeaway: The data suggest rhythm control should be considered a first-line strategy for STR management in AF patients, not reserved for select cases.
Why Does Rhythm Control Improve STR?
Secondary tricuspid regurgitation often worsens in the context of AF due to:
- Chronic atrial enlargement: AF leads to atrial dilation, which can distort the tricuspid valve annulus and impair leaflet coaptation.
- Right ventricular dysfunction: AF disrupts atrial kick, reducing preload to the right ventricle and contributing to tricuspid annular dilation.
- Pulmonary hypertension: Persistent AF may exacerbate pulmonary vascular resistance, further straining the tricuspid valve.
Restoring sinus rhythm addresses these mechanisms by:
- Normalizing atrial contractility and reducing annular dilation.
- Improving right ventricular filling and reducing volume overload.
- Potentially lowering pulmonary pressures over time.
What This Means for Patients and Clinicians
For Patients with AF and STR
- Ask about rhythm control: If you have moderate-to-severe STR and AF, discuss whether rhythm control strategies (e.g., catheter ablation, antiarrhythmic drugs) are appropriate for your case.
- Monitor for AF recurrence: Successful rhythm control requires ongoing management to prevent AF relapse, which could reverse STR improvements.
- Follow up with echocardiograms: Regular imaging can track STR progression and guide treatment adjustments.
For Cardiologists and Electrophysiologists
- Reevaluate treatment algorithms: Consider earlier and more aggressive rhythm control in AF patients with STR, particularly those with moderate-to-severe regurgitation.
- Prioritize antiarrhythmic therapy: The study highlights that lack of antiarrhythmic medication was associated with higher AF recurrence rates.
- Collaborate with heart failure specialists: STR management often requires a multidisciplinary approach, especially in patients with reduced LVEF or pulmonary hypertension.
- Educate patients on adherence: Emphasize the importance of medication compliance and lifestyle modifications to sustain sinus rhythm.
Frequently Asked Questions
Q: Is catheter ablation better than antiarrhythmic drugs for STR improvement?
A: The study did not directly compare ablation vs. Drugs, but both strategies can achieve rhythm control. Catheter ablation may offer longer-lasting results, particularly for persistent AF. The choice depends on patient-specific factors like AF type, comorbidities, and prior treatment responses.
Q: Can rhythm control reverse severe STR?
A: While rhythm control significantly improves STR severity in many cases, severe or long-standing STR may not fully resolve. However, reducing regurgitation to mild levels can still meaningfully improve symptoms and long-term outcomes.
Q: How soon after AF treatment should STR be reassessed?
A: The study suggests follow-up echocardiograms at 6–12 months after achieving rhythm control, as improvements in STR may take time to manifest. Earlier reassessment (e.g., 3 months) may be warranted in patients with rapid symptom improvement.
Q: Are there risks to aggressive rhythm control in older patients?
A: Older patients (median age 79 in this study) may have higher AF recurrence rates, but the benefits of rhythm control for STR often outweigh the risks. Careful patient selection, shared decision-making, and close monitoring are essential to balance risks and benefits.
5 Key Takeaways
- Rhythm control is associated with a 3.65-fold higher likelihood of STR improvement compared to failed rhythm control efforts.
- Benefits extend across all STR subtypes and patient characteristics, making rhythm control a broadly applicable strategy.
- Early intervention is critical: Delays in rhythm control may increase STR progression risk.
- AF recurrence undermines STR improvements, emphasizing the need for sustained sinus rhythm maintenance.
- Multidisciplinary care is essential, particularly for patients with coexistent heart failure or pulmonary hypertension.
Looking Ahead: Next Steps in Research and Clinical Practice
While this study provides strong evidence, several questions remain:
- Optimal timing: Should rhythm control be attempted at AF diagnosis, or only after STR progression?
- Combined therapies: Could rhythm control plus tricuspid valve interventions (e.g., annuloplasty) yield even better outcomes?
- Biomarkers: Are there predictive markers to identify patients most likely to benefit from rhythm control?
- Long-term durability: How long do STR improvements last after successful rhythm control?
Ongoing trials, such as those investigating novel antiarrhythmic drugs or minimally invasive tricuspid repair techniques, may further refine STR management strategies.
Expert Commentary: Dr. Natalie Singh
“This study is a game-changer for patients with AF and STR. For too long, clinicians have defaulted to rate control, assuming rhythm control was too aggressive or ineffective. Now, we have clear evidence that restoring sinus rhythm can meaningfully improve STR severity—and potentially delay or even obviate the need for surgical interventions like tricuspid valve repair.
However, it’s crucial to emphasize that rhythm control is not a one-size-fits-all solution. Patients must be carefully selected, and treatment plans should be individualized. The data also underscore the importance of adherence: AF recurrence can quickly reverse the benefits seen with rhythm control. Moving forward, shared decision-making between patients and providers will be key to optimizing these strategies.”